Malta - English - Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - simvastatin - film-coated tablet - simvastatin 10 mg - lipid modifying agents

Malta - English - Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - simvastatin - film-coated tablet - simvastatin 20 mg - lipid modifying agents

Malta - English - Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - simvastatin - film-coated tablet - simvastatin 40 mg - lipid modifying agents

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - sodium nitroprusside - injection, concentrated - excipient ingredients: water for injections - - immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside. - producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate. - short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - sodium nitroprusside - injection, concentrated - excipient ingredients: water for injections - - immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside. - producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate. - short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - sodium nitroprusside - injection, concentrated - excipient ingredients: water for injections - - immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside. - producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate. - short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

Australia - English - Department of Health (Therapeutic Goods Administration)

luminarie pty ltd - arsenic trioxide, quantity: 10 mg - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - for the induction of remission and consolidation in patients with acute promyelocytic leukaemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.,for the induction of remission and consolidation in patients with previously untreated acute promyelocytic leukaemia (apl), in combination with all-trans retinoic acid (atra) and/or chemotherapy and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: citric acid; hydrochloric acid; sodium chloride; sodium citrate dihydrate; disodium edetate; sodium hydroxide; water for injections - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).